Aurelius designs and manufactures compact, modular bioreactor systems for growing and processing CAR-T and engineered NK cells. The team includes biotech researchers from UNSW's Translational Research Institute and partners with clinical centres across Sydney, Melbourne, and Brisbane. The platform reduces batch-to-batch variability by 64% compared to manual processes.